compounded semaglutide side effects FDA alerts health care providers, compounders and patients of dosing errors associated with injectable products Hims GLP-1 Weight Loss Guide

Patients also stop because of cost, loss of insurance, or side effects

The safety and tolerability profile of retatrutide observed in the phase 2 trial was broadly consistent with that of other incretin-based therapies, including GLP-1 receptor agonists

But the full picture is more nuanced than that

Key Takeaways GLP-1 agonists are intended and approved to help with blood sugar regulation in type 2 diabetes patients, and in certain cases for clinical obesity, when no other methods have worked

There is no one-size-fits-all approach, and ongoing support can play a critical role in helping patients maintain their progress

Over time, losing muscle can slow your metabolism and make it harder to maintain your results long term